The choice of the RNA constructs was based on the sequence of the gene comprising an additional U at position 332. The RNAs assayed for crystallization of a complex with the La module of LARP7 were 302-332, 300-332 and 287-332 comprising the HP4 hairpin, and the 
purified by anionic exchange on MonoQ followed by extensive dialysis against storage buffer (10 mM Na cacodylate, pH 6.5, 2 mM MgCl2, 0.25 mM EDTA).
LARP7 full-length and the truncated versions were cloned in bacterial expression plasmids of the pnEA family {Diebold, 2011 #757}, derived from pET15. The plasmid producing an Nterminal His-tag (pnEA-NH) and TEV cleavage site was chosen for all proteins, except for fulllength LARP7 which was produced with a C-terminal His-tag, and the crystallized N-terminal domain (amino acids 1-208) for which the P3C cleavage site was used. Expression of proteins, after transformation in E. coli BL21-derived strain Rosetta (Novagen), was obtained by culture in auto-inducible medium at 28°C. Lysis was performed by sonication in the presence of 50 mM Tris, pH 7.6, 500 mM NaCl, 5 mM MgCl 2 , 1.4 mM ß-mercapto-ethanol and protease inhibitors. After debris elimination, purification was performed in batch mode on Ni-beads. The tag was cleaved by overnight incubation with TEV (or P3C) during a dialysis into 20 mM Sodium HEPES, pH 7.2, 1 mM EDTA, 2 mM DTT and NaCl (300 mM for LARP fulllength, 200 mM for domains). A cationic exchange chromatography was performed on HiLoad SP-Sepharose (GE Healthcare), followed by dialysis in storage buffer (same as dialysis buffer, above) and concentration by ultra-filtration. For biochemical usage, proteins at 10-50 µM were kept in aliquots at -80°C after addition of 10% glycerol and flash-freezing in liquid nitrogen. For crystallization, the final dialysis step was replaced by a size-exclusion chromatography on Superdex 75.
Circular dichroism
A potential unfolding of the E130A mutant version of the La module was checked by circular dichroïsm (CD). CD spectra were recorded using a Jobin-Yvon Mark VI circular dichrograph at a scan speed of 0,2 nm/s. Quartz spare cuvette with 0,1 cm path length was used. Blanks were run before each spectrum and subtracted from the raw data. Three spectra were averaged to increase the signal-to-noise ratio. The final proteins (wild-type and E130A) were in Hepes buffer (same buffer as in the final step of protein purification) or phosphate buffer (100 mM phospahte pH 7.5) and the assays were carried out at 20°C. The results are presented as normalized Δε values on the basis of the amino acid residue mass of 110 Da.
Taking into account a sensitivity of δ(ΔA) = 10 -6 for the apparatus, the protein concentration and the optical path-length of the cuvette, measurements were obtained at a precision of δ(Δε) = +/-0,002 M -1 .cm -1 per amino acid. The mutant E130A showed similar spectra as the wild-type protein in both buffers. 
Crystallization of complexes of

Experimental details for EMSAs and footprinting.
The RNAs were labeled at the 5′-end with T4 polynucleotide kinase (Fermentas) and Υ-32 P-ATP, following dephosphorylation with antarctic phosphatase (Biolabs). For 7SK, an additional purification on a denaturing gel was performed to eliminate fragments resulting from degradation. Thermal treatment (3 min at 90°C, followed by 5 min on ice) was necessary with 7SK to get one single band on a native gel. This treatment also helped to minimize the formation of duplexes, which formed spontaneously at RNA concentration higher than 0.5 µM, especially in the case of short RNAs such as 302-332. Interestingly, such duplexes elicited efficient binding ( Supplementary Fig. S3 ).
Complexes were formed by incubation at 4°C of 50 nm RNA with proteins in the range of 0-2 µM for full-length and 0-10 µM for domains, in a buffer containing 25 mM Na HEPES, pH 7.2, 5 mM MgCl 2 , 250 mM NaCl, 2 mM DTT, 0.005% NP40, 10% glycerol, 0.05 mg/ml bovine serum albumin as well as 5 µM total tRNA to minimize non-specific binding. A small amount (1.5 µL) of dye mix containing 0.02% each of bromophenol blue and xylene cyanol in 60% glycerol was added to the 12 µL assay mix just before loading on a native gel in TBE (0.5X).
For the small RNAs and hairpins, vertical gels (20 x 20 cm, 1.5 mm thickness) were prepared with 6% acrylamide (29:1), and run at 4 W for 75 minutes. For larger complexes with 7SK, gels (20 x 24, 5 mm thickness) were prepared with agarose (1.6%) and run horizontally in TBE 0.5X at 6W. In this case, RNAs were transferred on nitrocellulose membranes. Gels were revealed by phosphorimaging. Band intensities were quantified with ImageJ. Curves [bound/ (bound+unbound)] were drawn with Excel.
For footprinting, the 262-HP4 RNA was gel-purified after labelling, and incubated at 4°C with or without proteins, in a volume of 10 µL, in a buffer containing 25 mM Na HEPES, pH 7.2, 5 mM MgCl 2 , 250 mM NaCl, 2 mM DTT, 0.005% NP40, 0.05 mg/ml bovine serum albumin and 5 µM total tRNA. After 15 minutes, allowing for complex formation, 1 µL RNase T1 (Ambion; diluted 1/1000) or V1 (Ambion; diluted 1/10) was added. After 5 minutes cleavage at room temperature, gel-loading buffer was added with either 10 mM EDTA or 10 mM MnCl 2 for stopping V1 or T1 reactions, respectively. Reactions were immediately loaded on a sequencing gel (20x40 cm, 0.4 mm thick, 15% acrylamide in urea 8M and TBE), together with an alkaline ladder and RNase T1 in denaturing conditions for sequence indexation, and migrated at 20W. Our working model in the region of the apical loop of HP4, showing the P65 structure as a purple ribbon. The residues in stick are predicted to be involved in RNA binding, either because they belong to the RNP-2 (purple, Tyr407 in P65, Tyr483 in human LARP7), or correspond to LARP7-specific residues (Tyr513 and Lys517 in P65 align with Lys535 and Asp539 in LARP7, respectively). (C) EMSA of the C-terminal domain of LARP7 with M1-HP4, either wild-type (WT) or mutated at the LARP7-specific residues Lys535 and Asp539.
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